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Abstract
In order to develop a new experimental animal model of infection with
Mycobacterium chelonae in keratomileusis, we conducted a double-
blind prospective study on 24 adult male New Zealand rabbits. One
eye of each rabbit was submitted to automatic lamellar keratotomy
with the automatic corneal shaper under general anesthesia. Eyes were
immunosuppressed by a single local injection of methyl prednisolone.
Twelve animals were inoculated into the keratomileusis interface with
1 µl of 106 heat-inactivated bacteria (heat-inactivated inoculum con-
trols) and 12 with 1 µl of 106 live bacteria. Trimethoprim drops (0.1%,
w/v) were used as prophylaxis for the surgical procedure every 4 h (50
µl, qid). Animals were examined by 2 observers under a slit lamp on
the 1st, 3rd, 5th, 7th, 11th, 16th, and 23rd postoperative days. Slit lamp
photographs were taken to document clinical signs. Animals were
sacrificed when corneal disease was detected and corneal samples
were taken for microbiological analysis. Eleven of 12 experimental
rabbits developed corneal disease, and M. chelonae could be isolated
from nine rabbits. Eleven of the 12 controls receiving a heat-inacti-
vated inoculum did not develop corneal disease. M. chelonae was not
isolated from any of the control rabbits receiving a heat-inactivated
inoculum, or from the healthy cornea of control rabbits. Corneal
infection by M. chelonae was successfully induced in rabbits submit-
ted to keratomileusis. To our knowledge, this is the first animal model
of M. chelonae infection following corneal flaps for refractive surgery
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Introduction
Non-tuberculous mycobacteria comprise
more than 90 species and are ubiquitous
microorganisms widely distributed in the en-
vironment. They are classified as rapidly
growing mycobacteria, which grow in less
than 7 days, and slowly growing mycobac-
teria, requiring culture for periods of 2-4
weeks (1).
Mycobacterium fortuitum, M. abscessus
and M. chelonae are rapidly growing myco-
bacteria  recognized as pathogenic to the eye.
Turner and Stinson (2) described the first
corneal infection caused by M. fortuitum
after removal of a foreign body in 1965.
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Keratitis caused by M. chelonae in patients
undergoing laser in situ keratomileusis
(LASIK) has only been described recently
(3,4).
Infectious keratitis is a severe complica-
tion of LASIK that can potentially reduce the
best final visual acuity. An incidence of
infectious keratitis of 1:5000 was reported
among patients submitted to LASIK, although
the real incidence is unknown (5). With the
growing number of refractive surgeries, an
increase in the incidence of keratitis caused
by non-tuberculous mycobacteria is expected.
M. chelonae is an opportunistic pathogen
and in most cases non-tuberculous myco-
bacterial keratitis is related to exogenous
inoculation of the microorganism. Since the
LASIK interface confines the causative agent
to replication under the suboptimal condi-
tions of the stroma (6), it could be ques-
tioned whether keratomileusis itself would
favor this infection.
Most patients with this infection have a
predisposing injury (including surgery) and
there is frequently a latent period of 2-8
weeks after corneal insult before keratitis
appears (7). A clinical presentation of infec-
tious crystalline keratopathy with an indo-
lent, slowly progressive course and with gray-
whitish, stellate, round or needle-like opaci-
ties can also be observed (6). Severe necro-
sis may sometimes be found (2).
Treatment of infectious keratitis may be
difficult and response to therapy is slow due
to delayed diagnosis, inadequate drug pen-
etration and resistance to most conventional
antibiotics (3,7,8).
We describe a new experimental model
of M. chelonae keratitis in the eyes of rabbits
undergoing automatic lamellar keratotomy.
This model can be used for studies on myco-
bacterial keratitis, as well as for the analysis
of therapeutic responses.
Material and Methods
Surgery, inoculations, clinical evaluation,
and cultures were performed in a prospec-
tive and double-blind fashion.
Animals
Three experiments, each involving eight
adult male New Zealand white rabbits each
weighing 3.5 to 4.0 kg, were performed.
Rabbits were maintained according to the
Institutional Guidelines and the Statement
for the Use of Animals in Ophthalmologic
and Vision Research. Rabbits underwent
previous biomicroscopy examination.
Bacteria
M. chelonae was isolated from a patient
with a diagnosis of mycobacterial keratitis
following LASIK. Bacteria were initially iso-
lated in blood-agar, Sabouraud, and thiogly-
colate media, and were also cultivated in
Middlebrook 7H9 broth (Difco) supple-
mented with oleic acid-albumin-dextrose-
catalase (7H9-OADC; Becton Dickinson)
and Middlebrook 7H10 agar (Difco) plates
supplemented with OADC, and Luria-Bertani
(LB) agar (1.5% (w/v) agar, 1.0% (w/v)
tryptone, 0.5% (w/v) yeast extract, and
1.0% (w/v) NaCl). Identification was per-
formed using PCR-restriction enzyme anal-
ysis, by analysis of the digestion patterns of
a fragment of the hsp65 gene, amplified by
PCR and restricted with enzymes BstEII and
HaeIII (9). Bacteria were kept in aliquots in
7H9-OADC plus 15% glycerol at -70ºC.
Bacteria in the initial log phase (4 days of
culture in 7H9-OADC at 30°C in a shaking
incubator) were prepared for inoculation.
Turbidity of the bacterial suspension was
visually compared to tube 5 of McFarland’s
scale (1.5 x 109 bacteria/ml) and absorbance
at 600 nm was  determined with a  spectro-
photometer (Hitachi® - U2000). One aliquot
of each suspension was plated onto LB agar
immediately after inoculation of the rabbits
and the plates were incubated at 30°C. The
bacterial concentration of the inoculum was
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determined on the basis of the number of
colony forming units. A control inoculum
was prepared in the same way, but the bacte-
ria were heat-inactivated for 20 min at 80°C.
After inoculation of the heat-inactivated con-
trol, 1 µl of the suspension was plated onto
LB agar to confirm bacterial inactivity.
Surgical procedure
Animals were anesthetized by intramus-
cular injections of xylazine (5 mg/kg) and
ketamine (25 mg/kg). The left eye also re-
ceived topical anesthesia with 0.5% pro-
paracaine hydrochloride. Local antisepsis
was performed with 10% povidone-iodine
(on the fur) and 5% (on the eyes). Fur and
lashes were isolated with a sterile plastic
sheet. The eye was proptosed and rinsed
with balanced saline solution. A line was
traced on the corneal surface using a gentian
violet pencil in order to aid the repositioning
of the keratomileusis flap. A nasal-based
corneal flap with a diameter of 9.5 mm and a
thickness of 160 µm was created using an
automated microkeratome - Automatic Cor-
neal Shaper (ACS No. 196, Chiron-Bausch
& Lomb, Irvine, CA, USA). The flap was
lifted using a spatula and the posterior face
of the disk and the bed was dried with a
polyvinyl acetate sponge.
Infection of the operated eyes
One microliter containing approximately
106 colony forming units of live or heat-
inactivated M. chelonae was placed into the
keratomileusis interface. The suspensions
were randomly distributed in a blind fashion
during the experiment. After disk reposition
and surface drying, subconjunctival injec-
tion of 20 mg methyl prednisolone acetate
was performed to promote local immuno-
suppression. One drop of a wide spectrum
antibiotic (0.1% trimethoprim (w/v) without
preservatives) was applied immediately af-
ter the surgical procedure and every 4 h
during the postoperative follow-up period
for antibiotic prophylaxis. Susceptibility tests
confirmed that the M. chelonae strain used
in this study was resistant to this antibiotic at
this concentration.
Postoperative evaluation
Two different examiners observed the
animals postoperatively by biomicroscopy
on days 1, 3, 5, 7, 11, 16, and 23 post-
inoculation. Photographic documentation
was obtained with a Topcon Slit Lamp (SL)-
7E (Tokyo, Japan).
Animals were sacrificed when clinical signs
of disease were detected (corneal infiltrates,
edema, ulcer). Specimens were processed for
laboratory work-up on the same day.
Cornea laboratory work-up
Removal of the corneal button was per-
formed under aseptic conditions. The eye
was proptosed, and before trephination the
corneal flap was lifted and the stromal bed
was scraped with a disposable blade for
smears and for culture analysis. The flap was
repositioned and a corneal trephination was
performed using a disposable trephine 12.0
mm in diameter up to 2/3 of the corneal
thickness. The anterior chamber was ap-
proached with a disposable blade and en-
trance was completed up to its total thick-
ness with scissors. The button was placed in
2.0 ml 7H9-OADC culture medium and im-
mediately processed.
One animal in each experiment was cho-
sen in a random fashion to have its contralat-
eral cornea (without surgery and without
disease) recovered to serve as negative con-
trol (healthy contralateral eye of infected
rabbits).
Specimen processing
All procedures were carried out under a
laminar flow, using sterile gloves. All instru-
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ments were changed between samples in
order to avoid cross-contamination. Corneal
buttons were cut up into small pieces, placed
in a porcelain container and then macerated
in 2.0 ml 7H9-OADC. One aliquot of the
suspension was diluted 1:10 in 7H9-OADC.
Non-diluted and diluted aliquots were then
plated onto LB agar containing antimicro-
bial agents to avoid secondary contamina-
tion (vancomycin hydrochloride (500 mg, 6
µg/ml; Eurofarma, São Paulo, SP, Brazil),
polymixin B sulfate (5000 IU, 15 µg/ml;
Sigma-Aldrich Co.), and amphotericin B
(Fungizone®, 50 mg, 5 µg/ml; Bristol-Myers
Squibb) and incubated at 30ºC until the ap-
pearance of colonies. Non-diluted and di-
luted aliquots were maintained in 7H9-
OADC. The presence of mycobacteria was
confirmed by Ziehl-Neelsen staining and
PCR-restriction enzyme analysis.
Results
The initial biomicroscopic corneal as-
pect was that of a mild lamellar keratitis
(Figure 1A). Clinical findings evolved to the
appearance of small and fine dots (“sands of
Sahara” aspect) (Figure 1B) or of a “cracked
windshield” lesion (Figure 1C) without sur-
rounding edema. A corneal abscess with
feathery margins was also observed under a
slit lamp (Figure 1D). Disease started on the
5th postoperative day. Eleven experimental
rabbits developed clinical corneal disease
and one died before developing corneal dis-
ease. Eleven control rabbits receiving heat-
inactivated inoculum did not develop cor-
neal disease. One rabbit in this group had a
secondary infection with Gram-positive cocci
and fungi. No healthy cornea control rabbit
developed clinical disease. M. chelonae was
isolated from 9 of 11 experimental rabbits,
but not from any of the heat-inactivated in-
oculum control rabbits nor from any healthy
cornea control rabbits.
Table 1 shows the clinical and laboratory
results obtained in three series of experiments.
Figure 1. Clinical aspect of cor-
neal disease by Mycobacterium
chelonae in rabbits submitted to
automatic lamellar keratotomy.
A, Corneal interface with an ini-
tial, mild lamellar keratitis. B,
Small and fine dots (“sands of
Sahara” appearance). C,
“Cracked windshield” appear-
ance. D, Corneal abscess with
feathery margins.
Table 1. Clinical and laboratory results obtained with the model of Mycobacterium
chelonae infection of rabbits described in the present study.
Inoculum Corneal disease AARB
Rabbit series I
1 Live + +
2 Live + +
3 Live + -
4 Heat-inactivated - -
5 Heat-inactivated - -
6 Heat-inactivated + -
7 Live + +
8 Heat-inactivated - -
9 Healthy cornea control - -
Rabbit series II
1 Heat-inactivated - -
2 Live + +
3 Heat-inactivated - -
4 Live + +
5 Live + +
6 Live + -
7 Heat-inactivated - -
8 Heat-inactivated - -
9 Healthy cornea control - -
Rabbit series III
1 Live + +
2 Heat-inactivated - -
3 Heat-inactivated - -
4 Live + +
5 Live Rabbit death Rabbit death
6 Live + +
7 Heat-inactivated - -
8 Heat-inactivated - -
9 Healthy cornea control - -
AARB = alcohol-acid-resistant bacilli, identified by PCR-restriction enzyme analysis as
M. chelonae; CFU = colony forming units. Series I, inoculum = 1.28 x 106 CFU; series
II, inoculum = 1.06 x 106 CFU; series III, inoculum = 1.03 x 106 CFU.
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Discussion
LASIK is accepted as an effective surgi-
cal procedure for the correction of refractive
errors (10). The rapid recovery of vision and
predictability are advantages of this tech-
nique. However, complications such as in-
fectious keratitis, although believed to be
rare, have been reported in the literature and
are considered to be sight-threatening (5,11).
Mycobacteria, previously regarded as un-
usual organisms, have been recently reported
as causative agents of outbreak infections
following LASIK (8,12). The occurrence of
keratitis in clusters following LASIK, an
elective surgery with good prognosis, may
be considered to be a very severe complica-
tion.
Available data about infection with the
M. chelonae-abscessus and M. fortuitum
groups are confusing, since these bacteria
were previously described as belonging to
the same subspecies or as being biovariants
(13). With the recent introduction and evolu-
tion of molecular techniques, there is strong
evidence that these are, in fact, two separate
species (14). However, when analyzing pre-
vious studies, it is difficult to recognize and
establish which species was, in fact, respon-
sible for the disease, particularly in reports
written before 1990 (14).
In the past, most experimental studies
involving infection by atypical mycobacte-
ria in rabbit eyes were performed using dif-
ferent strains of M. fortuitum. This species
was probably chosen because of its strong
pathogenicity to man and/or its frequent in-
volvement in disease at that time, or even
due to the lack of sophisticated methods of
identification to allow separation of groups
into different species.
Rabbits have been frequently used as
experimental animals in ophthalmology (15)
because of their eye structure (similar to the
human eye), cornea size, and capability of
being examined by slit lamp. In addition, the
rabbit cornea can be submitted to keratomil-
eusis. There are some difficulties in produc-
ing mycobacterial keratitis in this animal
model, possibly due to their natural resis-
tance. It has been known that rabbits are in
fact resistant to infection by atypical myco-
bacteria which are pathogenic to man (16,17).
According to Kushner et al. (18), non-tuber-
culous mycobacteria are virulent to mice,
less so to rabbits and will not infect guinea
pigs. Several attempts to develop an animal
model of non-tuberculous mycobacterial
keratitis have been unsuccessful. In 1966,
Levenson and Harrison (16) reported an ap-
parent high degree of resistance of the rabbit
cornea to infection by M. fortuitum isolates
from their patients.
Turner (17) reported some of the caus-
ative factors for the formation of corneal
ulcer by M. fortuitum in rabbits. Using dif-
ferent methods to diminish corneal resis-
tance prior to inoculation, as well as differ-
ent techniques of inoculation, he observed
that it was necessary to modify host resis-
tance or to increase the virulence of the
bacilli. He reported that pretreatment with
topical corticosteroids 2 weeks prior to in-
oculation facilitated the development of
keratitis. In 1992, Paschal et al. (19) ob-
served that a single subconjunctival injec-
tion of methylprednisolone, an intermedi-
ate-acting corticosteroid, at the time of my-
cobacteria inoculation was enough to cause
immunosuppression and induce indolent
keratitis, and that treatment with corticoste-
roids before inoculation was not necessary.
This approach was followed in the present
study.
An important aspect of this animal model
is related to the inoculum. In pilot studies, it
was observed that the viability of this clini-
cal strain of M. chelonae was reduced 2 h
after thawing (data not shown). For this rea-
son, inoculum suspensions were prepared 1
h before inoculation from freshly cultivated
bacteria.
In order to avoid waste during flap repo-
sition, we inoculated 106 bacteria/µl. Turner
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Table 2. Summary of published animal models of keratitis induced by non-tuberculous mycobacteria.
Bacteria Number of microorganisms State of the Animal Reference
 in the inoculum  organisms inoculation
M. fortuitum 6 x 104 Viable Intrastromal Turner (17)
M. marinum 6 x 104 Viable Intrastromal Turner (17)
M. fortuitum <2000; >106 Viable or killed Anterior chamber Kirber et al. (20)
M. fortuitum 104 Viable Intrastromal Paschal et al. (19)
M. fortuitum 104 Viable Intrastromal Helm et al. (21)
M. fortuitum 104 Viable Intrastromal Lin et al. (22)
M. chelonae 104 Viable Intrastromal Lin et al. (22)
M. fortuitum 104 Viable Intrastromal Hu and Wang (23)
M. chelonae 104 Viable Intrastromal Hu and Wang (23)
Eyes were immunosuppressed in Refs. 17, 19, 21, 22, and 23. Ref. 17 used 0.1 ml of a 6 x 105 organisms/
ml suspension. Refs. 19, 21, 22, and 23 used 10 µl of a 106/ml suspension.
(17), using 0.1 ml of a 600,000 organisms/ml
suspension (by McFarland’s technique), pro-
duced infection in rabbit corneas by stromal
injection. Kirber et al. (20) injected different
preparations of live and killed M. fortuitum
into the anterior chamber of the rabbit eye
and observed that preparations containing
up to 2000 viable organisms were ineffec-
tive in eliciting a reaction. Animals that re-
ceived an inoculum containing more than
107 organisms developed keratitis and reac-
tion in the anterior chamber within 24 h. In
his experimental animal model using M.
fortuitum, Paschal et al. (19), followed by
Helm et al. (21), Lin et al. (22), and Hu and
Wang (23) (the last two groups using the
same model and also M. chelonae) inocu-
lated 104 organisms (10 µl, 106 organisms/
ml) by intrastromal corneal injection to pro-
duce non-tuberculous mycobacterial kerati-
tis. Paschal et al. (19), in 1992, confirmed
the observations reported by Turner (17),
showing that isolated inoculation of M.
fortuitum into the rabbit cornea produced a
self-limited stromal keratitis (17,19); see
Table 2 for a summary of published animal
models.
Since trauma and surgery seem to be
factors predisposing to M. chelonae infec-
tion (24), in the present study we investi-
gated the possibility that during LASIK there
is mechanical trauma and inoculation of bac-
teria into the interface may occur. In previ-
ous reports, inoculation was carried out by
intrastromal injection with a Hamilton sy-
ringe, but keratomileusis was not simulated.
The clinical appearance of the keratitis
observed in this animal model was similar to
that described in human disease (7,8): well
demarcated or irregular edges with a snow-
flake or “cracked windshield” appearance,
along with multiple, fine, small opacities in
some animals. However, epithelial defects,
described by Broadway et al. (7) as being
universal, were not observed in this study, or
in studies by other authors (8).
In conclusion, although infectious kerati-
tis after LASIK is rare, M. chelonae is the
most frequently reported species among the
non-tuberculous mycobacteria involved in
keratitis. It is a severe condition, in which
diagnosis may be delayed and treatment is
difficult.
We describe here an experimental ani-
mal model with great potential of producing
infectious keratitis by M. chelonae follow-
ing keratomileusis. Regardless of some dif-
ferences between disease in the rabbit model
and in humans, this model can be used in
studies on the natural course and treatment
of keratitis, in order to obtain a better prog-
nosis for this severe and sight-threatening
condition.
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